NO990076L - FremgangsmÕte for behandling og forhundring av nevrodegenerative tilstander ved administrasjon av tiazolidinon - Google Patents
FremgangsmÕte for behandling og forhundring av nevrodegenerative tilstander ved administrasjon av tiazolidinonInfo
- Publication number
- NO990076L NO990076L NO990076A NO990076A NO990076L NO 990076 L NO990076 L NO 990076L NO 990076 A NO990076 A NO 990076A NO 990076 A NO990076 A NO 990076A NO 990076 L NO990076 L NO 990076L
- Authority
- NO
- Norway
- Prior art keywords
- thiazolidinone
- pct
- administration
- treating
- neurodegenerative conditions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2157196P | 1996-07-11 | 1996-07-11 | |
| PCT/US1997/011586 WO1998002160A1 (en) | 1996-07-11 | 1997-07-01 | Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO990076L true NO990076L (no) | 1999-01-08 |
| NO990076D0 NO990076D0 (no) | 1999-01-08 |
Family
ID=21804973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO990076A NO990076D0 (no) | 1996-07-11 | 1999-01-08 | FremgangsmÕte for behandling og forhundring av nevrodegenerative tilstander ved administrasjon av tiazolidinon |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5912259A (no) |
| EP (1) | EP0914122B1 (no) |
| JP (1) | JP2001508028A (no) |
| KR (1) | KR20000023683A (no) |
| CN (1) | CN1145481C (no) |
| AT (1) | ATE250416T1 (no) |
| AU (1) | AU726664B2 (no) |
| BR (1) | BR9710467A (no) |
| CA (1) | CA2255073A1 (no) |
| CO (1) | CO4940509A1 (no) |
| DE (1) | DE69725147T2 (no) |
| DK (1) | DK0914122T3 (no) |
| ES (1) | ES2205247T3 (no) |
| HK (1) | HK1020533A1 (no) |
| HR (1) | HRP970362A2 (no) |
| IL (1) | IL127487A (no) |
| NO (1) | NO990076D0 (no) |
| NZ (1) | NZ332763A (no) |
| PL (1) | PL331049A1 (no) |
| PT (1) | PT914122E (no) |
| TR (1) | TR199900040T2 (no) |
| WO (1) | WO1998002160A1 (no) |
| ZA (1) | ZA976142B (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7410797B2 (en) * | 2002-06-11 | 2008-08-12 | Ogle Roy C | Meningeal-derived stem cells |
| US20110104296A1 (en) * | 2008-05-08 | 2011-05-05 | Dipak Kumar Sarkar | Endorphin Therapy Compositions and Methods |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT83152B (pt) * | 1985-08-09 | 1989-03-30 | Lilly Co Eli | Processo para a preparacao de compostos di-t-butilfenoicos |
| EP0391644B1 (en) * | 1989-04-07 | 1996-06-19 | Eli Lilly And Company | Aryl-substituted rhodanine derivatives |
| US5143928A (en) * | 1990-03-27 | 1992-09-01 | Warner-Lambert Company | 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents |
| US5192753A (en) * | 1991-04-23 | 1993-03-09 | Mcgeer Patrick L | Anti-rheumatoid arthritic drugs in the treatment of dementia |
| ZA936492B (en) * | 1992-09-10 | 1995-03-02 | Lilly Co Eli | Compounds useful as hypoglycemic agents and for treating Alzheimer's disease. |
| WO1996022772A1 (en) * | 1995-01-23 | 1996-08-01 | Eli Lilly And Company | Method for treating multiple sclerosis |
| DE69635048T2 (de) * | 1995-06-12 | 2006-02-16 | G.D. Searle & Co. | Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor |
-
1997
- 1997-07-01 WO PCT/US1997/011586 patent/WO1998002160A1/en active IP Right Grant
- 1997-07-01 US US09/171,891 patent/US5912259A/en not_active Expired - Fee Related
- 1997-07-01 PT PT97933264T patent/PT914122E/pt unknown
- 1997-07-01 JP JP50606698A patent/JP2001508028A/ja not_active Ceased
- 1997-07-01 BR BR9710467A patent/BR9710467A/pt not_active Application Discontinuation
- 1997-07-01 CN CNB971960429A patent/CN1145481C/zh not_active Expired - Fee Related
- 1997-07-01 CA CA002255073A patent/CA2255073A1/en not_active Abandoned
- 1997-07-01 DK DK97933264T patent/DK0914122T3/da active
- 1997-07-01 NZ NZ332763A patent/NZ332763A/xx unknown
- 1997-07-01 PL PL97331049A patent/PL331049A1/xx unknown
- 1997-07-01 TR TR1999/00040T patent/TR199900040T2/xx unknown
- 1997-07-01 AT AT97933264T patent/ATE250416T1/de not_active IP Right Cessation
- 1997-07-01 AU AU36491/97A patent/AU726664B2/en not_active Ceased
- 1997-07-01 ES ES97933264T patent/ES2205247T3/es not_active Expired - Lifetime
- 1997-07-01 EP EP97933264A patent/EP0914122B1/en not_active Expired - Lifetime
- 1997-07-01 DE DE69725147T patent/DE69725147T2/de not_active Expired - Fee Related
- 1997-07-01 IL IL12748797A patent/IL127487A/en not_active IP Right Cessation
- 1997-07-03 HR HR60/021,571A patent/HRP970362A2/xx not_active Application Discontinuation
- 1997-07-10 CO CO97038493A patent/CO4940509A1/es unknown
- 1997-07-10 ZA ZA9706142A patent/ZA976142B/xx unknown
-
1999
- 1999-01-08 NO NO990076A patent/NO990076D0/no not_active Application Discontinuation
- 1999-01-09 KR KR1019997000140A patent/KR20000023683A/ko active IP Right Grant
- 1999-11-30 HK HK99105554A patent/HK1020533A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0914122B1 (en) | 2003-09-24 |
| NZ332763A (en) | 2000-07-28 |
| JP2001508028A (ja) | 2001-06-19 |
| PT914122E (pt) | 2003-12-31 |
| DE69725147T2 (de) | 2004-07-22 |
| WO1998002160A1 (en) | 1998-01-22 |
| AU3649197A (en) | 1998-02-09 |
| PL331049A1 (en) | 1999-06-21 |
| EP0914122A1 (en) | 1999-05-12 |
| US5912259A (en) | 1999-06-15 |
| CO4940509A1 (es) | 2000-07-24 |
| CN1145481C (zh) | 2004-04-14 |
| DE69725147D1 (de) | 2003-10-30 |
| KR20000023683A (ko) | 2000-04-25 |
| IL127487A0 (en) | 1999-10-28 |
| ES2205247T3 (es) | 2004-05-01 |
| BR9710467A (pt) | 1999-08-17 |
| HK1020533A1 (en) | 2000-05-12 |
| DK0914122T3 (da) | 2003-12-22 |
| ZA976142B (en) | 1998-02-02 |
| TR199900040T2 (xx) | 1999-04-21 |
| NO990076D0 (no) | 1999-01-08 |
| HRP970362A2 (en) | 1998-04-30 |
| CN1223582A (zh) | 1999-07-21 |
| IL127487A (en) | 2002-04-21 |
| ATE250416T1 (de) | 2003-10-15 |
| CA2255073A1 (en) | 1998-01-22 |
| AU726664B2 (en) | 2000-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2168829A1 (en) | Paroxetine hydrochloride anhydrate forms a,b,c and d | |
| DE69709070D1 (de) | Verbrückte zyklische aminosäuren als pharmazeutische mittel | |
| HK1053782A1 (en) | Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids | |
| ATE205086T1 (de) | Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit | |
| AU9125798A (en) | Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses | |
| ATE193442T1 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
| WO1999048489A3 (en) | Melatonin for delaying the onset of alzheimer's disease and for treating or delaying the onset of other amyloidosis-related diseases/disorders | |
| NO990076D0 (no) | FremgangsmÕte for behandling og forhundring av nevrodegenerative tilstander ved administrasjon av tiazolidinon | |
| EP1447090B8 (de) | Verwendung von Hyaluronidase zur Prophylaxe und Behandlung von Herz-Kreislauf-Erkrankungen | |
| SE9302218D0 (sv) | New use | |
| CA2181225A1 (en) | The use of sertraline to treat post myocardial infarction patients | |
| AU7230894A (en) | Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases | |
| DE69909970D1 (de) | Verwendung von 2-amino-6-trifluoromethoxybenzothiazol zur herstellung eines arzneimittels zur vorbeugung oder behandlung von zerebellumkrankheiten | |
| HUP9903936A2 (hu) | Tiazolidinonszármazék alkalmazása neurodegenerációs rendellenességek kezelésére és megelőzésére szolgáló gyógyszerkészítmények előállítására | |
| SE9501773D0 (sv) | New use | |
| FR2752163B1 (fr) | Utilisation de l'efaroxan pour la fabricaton de medicament destine au traitement de la maladie de huntington | |
| MX9701528A (es) | Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer. | |
| HUP0002639A2 (hu) | Eljárás a vastagbél bakteriális fertőzéséből eredő betegségek kezelésére |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |